{
    "1846.HK": {
        "short_name": "EUROEYES",
        "long_name": "EuroEyes International Eye Clinic Limited",
        "summary": "EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract surgeries. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in eye clinic equipment and lenses trading; and ophthalmic equipment renting and spaces operating activities. The company was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "20355",
        "website": "http://www.euroeyes.hk",
        "market_cap": 3279170560
    },
    "EIF.F": {
        "short_name": "EIFELHOEHEN-KLINIK O.N.",
        "long_name": "Eifelh\u00f6hen-Klinik AG",
        "summary": "Eifelh\u00c3\u00b6hen-Klinik AG operates facilities for outpatient and inpatient rehabilitation, elderly care, and outpatient medical care in Germany. It operates clinics that provide rehabilitation services in the areas of geriatrics, internal medicine, orthopedics, neurology, cardiology, and neurosurgery, as well as stroke diseases. The company also operates a care facility with 39 beds and a medical care center. Eifelh\u00c3\u00b6hen-Klinik AG was founded in 1970 and is headquartered in Bonn, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bonn",
        "zipcode": "53117",
        "website": "http://eifelhoehen-klinik.ag",
        "market_cap": 13276648
    },
    "FMCQF": {
        "short_name": "FRESENIUS MEDICAL CARE AG & CO ",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 23826438144
    },
    "FME.DE": {
        "short_name": "FRESEN.MED.CARE KGAA O.N.",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 20092116992
    },
    "FME.F": {
        "short_name": "FRESEN.MED.CARE KGAA O.N.",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 18779979776
    },
    "FME.MI": {
        "short_name": "FRESENIUS MEDICAL CARE",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 19928098816
    },
    "FME.VI": {
        "short_name": "FRESEN.MED.CARE KGAA",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 20121405440
    },
    "FMEA.F": {
        "short_name": "FRESENIUS MD.CARE ADR 1/2",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 19564918784
    },
    "FMS": {
        "short_name": "Fresenius Medical Care AG",
        "long_name": "Fresenius Medical Care AG & Co. KGaA",
        "summary": "Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg",
        "zipcode": "61352",
        "website": "http://www.freseniusmedicalcare.com",
        "market_cap": 24368281600
    },
    "FRE.DE": {
        "short_name": "FRESENIUS SE+CO.KGAA O.N.",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 24963069952
    },
    "FRE.F": {
        "short_name": "FRESENIUS SE+CO.KGAA O.N.",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 23816941568
    },
    "FRE.MI": {
        "short_name": "FRESENIUS",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 23409731584
    },
    "FRE.VI": {
        "short_name": "FRESENIUS SE+CO.KGAA",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 24973514752
    },
    "FREA.F": {
        "short_name": "FRESENIUS SE+CO. ADR 1/4",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 24174481408
    },
    "FREN.MX": {
        "short_name": "FRESENIUS SE&CO KGAA",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "MXN",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "MEX",
        "market": "mx_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 614989955072
    },
    "FSNUF": {
        "short_name": "FRESENIUS SE&CO KGAA",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 29557358592
    },
    "FSNUY": {
        "short_name": "FRESENIUS SE&CO KGAA",
        "long_name": "Fresenius SE & Co. KGaA",
        "summary": "Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune diseases and oncology; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operated 89 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 46 hospitals, 70 outpatient clinics, and approximately 300 risk prevention centers in Spain. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project consulting and development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der H\u00c3\u00b6he, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Homburg vor der H\u00c3\u00b6he",
        "zipcode": "61352",
        "website": "http://www.fresenius.com",
        "market_cap": 26330365952
    },
    "LIK.DE": {
        "short_name": "LIMES SCHLOSSKLINIK. O.N.",
        "long_name": "LIMES Schlosskliniken AG",
        "summary": "LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of G M F Capital Gmbh.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Cologne",
        "zipcode": "50672",
        "website": "http://www.limes-schlosskliniken.de",
        "market_cap": 46692128
    },
    "LIK.DU": {
        "short_name": "LIMES SCHLOSSKLINIK. O.N.",
        "long_name": "LIMES Schlosskliniken AG",
        "summary": "LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of G M F Capital Gmbh.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "DUS",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Cologne",
        "zipcode": "50672",
        "website": "http://www.limes-schlosskliniken.de",
        "market_cap": 47497104
    },
    "LIK.F": {
        "short_name": "LIMES SCHLOSSKLINIK. O.N.",
        "long_name": "LIMES Schlosskliniken AG",
        "summary": "LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of G M F Capital Gmbh.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Cologne",
        "zipcode": "50672",
        "website": "http://www.limes-schlosskliniken.de",
        "market_cap": 34300948
    },
    "M12.DE": {
        "short_name": "M1 KLINIKEN AG  O.N.",
        "long_name": "M1 Kliniken AG",
        "summary": "M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe. The company operates through Beauty and Trade segments. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine, plastic surgery, and cosmetic dermatology. The company also engages in the acquisition, development, operation, and sale of real estate, primarily in the health care sector. In addition, it offers its products to private customers, doctors, pharmacies, and wholesalers under the M1 Select and M1 Aesthetics brands. It operates a network of outpatient specialist centers for beauty treatments; and a specialist surgical clinic centres under the M1 Med Beauty, M1 Laser, and M1 Dental brand names. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Berlin",
        "zipcode": "12557",
        "website": "http://www.m1-kliniken.de",
        "market_cap": 221970416
    },
    "M12.F": {
        "short_name": "M1 KLINIKEN AG  O.N.",
        "long_name": "M1 Kliniken AG",
        "summary": "M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe. The company operates through Beauty and Trade segments. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine, plastic surgery, and cosmetic dermatology. The company also engages in the acquisition, development, operation, and sale of real estate, primarily in the health care sector. In addition, it offers its products to private customers, doctors, pharmacies, and wholesalers under the M1 Select and M1 Aesthetics brands. It operates a network of outpatient specialist centers for beauty treatments; and a specialist surgical clinic centres under the M1 Med Beauty, M1 Laser, and M1 Dental brand names. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Berlin",
        "zipcode": "12557",
        "website": "http://www.m1-kliniken.de",
        "market_cap": 223572816
    },
    "MAK.DE": {
        "short_name": "MATERNUS-KLI.AG O.N.",
        "long_name": "Maternus-Kliniken Aktiengesellschaft",
        "summary": "Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Berlin",
        "zipcode": "10117",
        "website": "http://www.maternus.de",
        "market_cap": 82621800
    },
    "MAK.F": {
        "short_name": "MATERNUS-KLI.AG O.N.",
        "long_name": "Maternus-Kliniken Aktiengesellschaft",
        "summary": "Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Berlin",
        "zipcode": "10117",
        "website": "http://www.maternus.de",
        "market_cap": 81721720
    },
    "MED.DE": {
        "short_name": "MEDICLIN AG",
        "long_name": "MEDICLIN Aktiengesellschaft",
        "summary": "MEDICLIN Aktiengesellschaft operates hospitals in Germany. It operates through Post-Acute, Acute, and Other Activities segments. It offers medical services focusing on cardiology, cardiac surgery, and cardiological rehabilitation services; acute neurological treatment and neurological early rehabilitation services; psychosomatic and psychiatry; orthopedics; geriatrics; treatment of diabetes, obesity and kidney diseases, chronic pain, and rehabilitation after cochlear implants; radiation therapy; internal medicine; and neurosurgery and neuroradiology. The company also provides services in the areas of oncology, and ENT, as well as acute outpatient services. As of January 01, 2021, it owned 35 clinics, 7 nursing care facilities, and 10 medical care centers with a total capacity of approximately 8,350 beds/ care places in 11 German federal states. The company is headquartered in Offenburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Offenburg",
        "zipcode": "77652",
        "website": "http://www.mediclin.de",
        "market_cap": 199499984
    },
    "MED.F": {
        "short_name": "MEDICLIN AG",
        "long_name": "MEDICLIN Aktiengesellschaft",
        "summary": "MEDICLIN Aktiengesellschaft operates hospitals in Germany. It operates through Post-Acute, Acute, and Other Activities segments. It offers medical services focusing on cardiology, cardiac surgery, and cardiological rehabilitation services; acute neurological treatment and neurological early rehabilitation services; psychosomatic and psychiatry; orthopedics; geriatrics; treatment of diabetes, obesity and kidney diseases, chronic pain, and rehabilitation after cochlear implants; radiation therapy; internal medicine; and neurosurgery and neuroradiology. The company also provides services in the areas of oncology, and ENT, as well as acute outpatient services. As of January 01, 2021, it owned 35 clinics, 7 nursing care facilities, and 10 medical care centers with a total capacity of approximately 8,350 beds/ care places in 11 German federal states. The company is headquartered in Offenburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Offenburg",
        "zipcode": "77652",
        "website": "http://www.mediclin.de",
        "market_cap": 201111200
    },
    "MKLNF": {
        "short_name": "M1 KLINIKEN AG",
        "long_name": "M1 Kliniken AG",
        "summary": "M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Europe. The company operates through Beauty and Trade segments. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine, plastic surgery, and cosmetic dermatology. The company also engages in the acquisition, development, operation, and sale of real estate, primarily in the health care sector. In addition, it offers its products to private customers, doctors, pharmacies, and wholesalers under the M1 Select and M1 Aesthetics brands. It operates a network of outpatient specialist centers for beauty treatments; and a specialist surgical clinic centres under the M1 Med Beauty, M1 Laser, and M1 Dental brand names. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Berlin",
        "zipcode": "12557",
        "website": "http://www.m1-kliniken.de",
        "market_cap": 250384128
    },
    "RHK.DE": {
        "short_name": "RHOEN-KLINIKUM O.N.",
        "long_name": "RH\u00d6N-KLINIKUM Aktiengesellschaft",
        "summary": "RH\u00c3\u0096N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Neustadt an der Saale",
        "zipcode": "97616",
        "website": "http://www.rhoen-klinikum-ag.com",
        "market_cap": 1046918144
    },
    "RHK.F": {
        "short_name": "RHOEN-KLINIKUM O.N.",
        "long_name": "RH\u00d6N-KLINIKUM Aktiengesellschaft",
        "summary": "RH\u00c3\u0096N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Neustadt an der Saale",
        "zipcode": "97616",
        "website": "http://www.rhoen-klinikum-ag.com",
        "market_cap": 1052256768
    },
    "RHK.VI": {
        "short_name": "RHOEN-KLINIKUM AG",
        "long_name": "RH\u00d6N-KLINIKUM Aktiengesellschaft",
        "summary": "RH\u00c3\u0096N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Neustadt an der Saale",
        "zipcode": "97616",
        "website": "http://www.rhoen-klinikum-ag.com",
        "market_cap": 1069867392
    },
    "RHKU.F": {
        "short_name": "RHOEN-KLINIK.UNSP.ADR 1/2",
        "long_name": "RH\u00d6N-KLINIKUM Aktiengesellschaft",
        "summary": "RH\u00c3\u0096N-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Bad Neustadt an der Saale",
        "zipcode": "97616",
        "website": "http://www.rhoen-klinikum-ag.com",
        "market_cap": 1076092544
    },
    "V3V.DE": {
        "short_name": "VITA 34 AG NA O.N.",
        "long_name": "VITA 34 AG",
        "summary": "VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Leipzig",
        "zipcode": "04103",
        "website": "http://www.vita34.de",
        "market_cap": 69668552
    },
    "V3V.F": {
        "short_name": "VITA 34 AG NA O.N.",
        "long_name": "VITA 34 AG",
        "summary": "VITA 34 AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company offers Sibling Initiative that offers free storage of stem cells collected from the umbilical cord blood of a child whose brother or sister is seriously ill and needs the stem cells from the newborn sibling for treatment purposes; VitaPlusDonation that stores stem cells for personal therapeutic stem cell application; and VitaMine&Yours, which combines the storage of umbilical cord blood for personal provision with the possibility of a donation. It also provides Prevention screenings, which enable the detection of genetically related health risks and predispositions; and mobile stem cell team that facilitates the treatment with stem cells from umbilical cord blood in various hospitals. The company was founded in 1997 and is based in Leipzig, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Care Facilities",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Leipzig",
        "zipcode": "04103",
        "website": "http://www.vita34.de",
        "market_cap": 68848888
    }
}